
- Trade $0 commission stocks & ETFs with as little as $1
- Earn up to $300 with qualifying deposits
- Discover new opportunities with Opto's AI-driven thematic investing system
- Theme and ETF screener
McKesson Corporation is a medical distribution business based in the US. McKesson Corporation shares (MCK) are listed on the NYSE and all prices are listed in US Dollars. Its last market close was $597.71 – an increase of 0.68% over the previous week. McKesson Corporation employs 45,000 staff and has a trailing 12-month revenue of around $344.6 billion.
The Finder Score crunches 147 key metrics we collected directly from 18+ brokers and assessed each provider’s performance based on nine different categories, weighing each metric based on the expertise and insights of Finder’s investment experts. We then scored and ranked each provider to determine the best brokerage accounts.
We update our best picks as products change, disappear or emerge in the market. We also regularly review and revise our selections to ensure our best provider lists reflect the most competitive available.
Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.
Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.
Latest market close | $597.71 |
---|---|
52-week range | $463.89 - $635.98 |
50-day moving average | $588.93 |
200-day moving average | $566.71 |
Wall St. target price | $662.08 |
PE ratio | 27.6586 |
Dividend yield | $2.66 (0.47%) |
Earnings per share (TTM) | $21.82 |
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Historical closes compared with the close of $603.51 from 2025-02-20
1 week (2025-02-14) | 1.65% |
---|---|
1 month (2025-01-22) | 3.27% |
3 months (2024-11-22) | -3.16% |
6 months (2024-08-22) | 7.60% |
1 year (2024-02-22) | 18.27% |
---|---|
2 years (2023-02-22) | 69.07% |
3 years (2022-02-22) | 128.08% |
5 years (2020-02-21) | 265.97% |
Valuing McKesson Corporation stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of McKesson Corporation's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
McKesson Corporation's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 28x. In other words, McKesson Corporation shares trade at around 28x recent earnings.
That's comparable to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29).
McKesson Corporation's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 1.0395. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into McKesson Corporation's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
McKesson Corporation's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $6.3 billion.
The EBITDA is a measure of a McKesson Corporation's overall financial performance and is widely used to measure a its profitability.
Revenue TTM | $344.6 billion |
---|---|
Operating margin TTM | 1.31% |
Gross profit TTM | $13.1 billion |
Return on assets TTM | 5.24% |
Return on equity TTM | 0% |
Profit margin | 0.82% |
Book value | $-24.48 |
Market Capitalization | $75.6 billion |
TTM: trailing 12 months
Dividend payout ratio: 9.12% of net profits
Recently McKesson Corporation has paid out, on average, around 0% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 0% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), McKesson Corporation shareholders could enjoy a 0% return on their shares, in the form of dividend payments. In McKesson Corporation's case, that would currently equate to about $2.66 per share.
While McKesson Corporation's payout ratio might seem low, this can signify that McKesson Corporation is investing more in its future growth.
McKesson Corporation's most recent dividend payout was on 31 March 2025. The latest dividend was paid out to all shareholders who bought their shares by 2 March 2025 (the "ex-dividend date").
McKesson Corporation's shares were split on a 2:1 basis on 4 January 1998 . So if you had owned 1 share the day before before the split, the next day you'd have owned 2 shares. This wouldn't directly have changed the overall worth of your McKesson Corporation shares – just the quantity. However, indirectly, the new 50% lower share price could have impacted the market appetite for McKesson Corporation shares which in turn could have impacted McKesson Corporation's share price.
Over the last 12 months, McKesson Corporation's shares have ranged in value from as little as $463.8904 up to $635.9769. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while McKesson Corporation's is 0.521. This would suggest that McKesson Corporation's shares are less volatile than average (for this exchange).
McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U. S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions, and International. The U. S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products.
Spot dogecoin ETFs might soon be approved. Here’s how to invest if and when they become available to trade.
Some of the best paper trading apps to practice stock trading with fake money include Interactive Brokers, eToro, Charles Schwab and more.
These are the best trading platforms for beginners, according to Finder’s comprehensive analysis.
Want to buy and sell international stocks? Here are the top brokers to help you trade global markets.
These are the best discount brokers of 2025 according to Finder’s comprehensive review.
Compare the 5 best stock picking services, according to Finder’s analysis, and learn how to choose the best option for your needs.
Check out our picks of the best trading apps for beginners, options traders, hands-off investors and more.
See our picks of the best brokerage accounts, including Fidelity, SoFi, Charles Schwab, Public, Robinhood and E*TRADE .
Top ways to invest $20K include stocks, retirement accounts, conservative investments, ETFs and more. See our full list here.
A deep dive into the highlights and limitations of Robinhood.